Secondary outcomes include change in waist circumference, change in BMI, change in percent body fat, change in visceral and subcutaneous adipose tissue, change in trunk fat mass, percentage of weight loss due to fat mass or lean mass, quality of life, and more
July 29, 2022
After 30 days of being on the 7 mg per day dosing, the dose may be increased to 14 mg once a day if needed for additional glycemic control
Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3.6 million adults in the UK
Clinical studies show that its typical to experience up to 15 percent weight loss after about a year on this medication
Other serious adverse events can include severe nausea and vomiting leading to dehydration, acute kidney injury, particularly in patients with existing kidney disease, and diabetic retinopathy complications in some patients with diabetes